nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—Infection—Carboplatin—bone cancer	0.0243	0.0243	CcSEcCtD
Zanamivir—Pain—Carboplatin—bone cancer	0.0209	0.0209	CcSEcCtD
Zanamivir—Lymphopenia—Epirubicin—bone cancer	0.0201	0.0201	CcSEcCtD
Zanamivir—Body temperature increased—Carboplatin—bone cancer	0.0193	0.0193	CcSEcCtD
Zanamivir—Lymphopenia—Doxorubicin—bone cancer	0.0186	0.0186	CcSEcCtD
Zanamivir—Lung disorder—Methotrexate—bone cancer	0.0156	0.0156	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Cisplatin—bone cancer	0.0151	0.0151	CcSEcCtD
Zanamivir—Lung disorder—Epirubicin—bone cancer	0.0146	0.0146	CcSEcCtD
Zanamivir—Face oedema—Cisplatin—bone cancer	0.0141	0.0141	CcSEcCtD
Zanamivir—Dehydration—Cisplatin—bone cancer	0.0136	0.0136	CcSEcCtD
Zanamivir—Lung disorder—Doxorubicin—bone cancer	0.0135	0.0135	CcSEcCtD
Zanamivir—Delirium—Epirubicin—bone cancer	0.012	0.012	CcSEcCtD
Zanamivir—Delirium—Doxorubicin—bone cancer	0.0111	0.0111	CcSEcCtD
Zanamivir—Musculoskeletal pain—Epirubicin—bone cancer	0.0104	0.0104	CcSEcCtD
Zanamivir—Influenza like illness—Epirubicin—bone cancer	0.01	0.01	CcSEcCtD
Zanamivir—Musculoskeletal pain—Doxorubicin—bone cancer	0.00966	0.00966	CcSEcCtD
Zanamivir—Influenza like illness—Doxorubicin—bone cancer	0.00926	0.00926	CcSEcCtD
Zanamivir—Arrhythmia—Cisplatin—bone cancer	0.00901	0.00901	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Methotrexate—bone cancer	0.00826	0.00826	CcSEcCtD
Zanamivir—Ill-defined disorder—Cisplatin—bone cancer	0.00814	0.00814	CcSEcCtD
Zanamivir—Increased appetite—Epirubicin—bone cancer	0.00797	0.00797	CcSEcCtD
Zanamivir—Malaise—Cisplatin—bone cancer	0.00791	0.00791	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Epirubicin—bone cancer	0.00773	0.00773	CcSEcCtD
Zanamivir—Convulsion—Cisplatin—bone cancer	0.0076	0.0076	CcSEcCtD
Zanamivir—Myalgia—Cisplatin—bone cancer	0.00747	0.00747	CcSEcCtD
Zanamivir—Anxiety—Cisplatin—bone cancer	0.00745	0.00745	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00742	0.00742	CcSEcCtD
Zanamivir—Discomfort—Cisplatin—bone cancer	0.00738	0.00738	CcSEcCtD
Zanamivir—Increased appetite—Doxorubicin—bone cancer	0.00737	0.00737	CcSEcCtD
Zanamivir—Face oedema—Epirubicin—bone cancer	0.00723	0.00723	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.0072	0.0072	CcSEcCtD
Zanamivir—Anaphylactic shock—Cisplatin—bone cancer	0.00716	0.00716	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Doxorubicin—bone cancer	0.00715	0.00715	CcSEcCtD
Zanamivir—Infection—Cisplatin—bone cancer	0.00712	0.00712	CcSEcCtD
Zanamivir—Dehydration—Epirubicin—bone cancer	0.00696	0.00696	CcSEcCtD
Zanamivir—Skin disorder—Cisplatin—bone cancer	0.00696	0.00696	CcSEcCtD
Zanamivir—Asthma—Methotrexate—bone cancer	0.00691	0.00691	CcSEcCtD
Zanamivir—Anorexia—Cisplatin—bone cancer	0.00683	0.00683	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00674	0.00674	CcSEcCtD
Zanamivir—Face oedema—Doxorubicin—bone cancer	0.00669	0.00669	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00653	0.00653	CcSEcCtD
Zanamivir—Influenza—Epirubicin—bone cancer	0.00647	0.00647	CcSEcCtD
Zanamivir—Asthma—Epirubicin—bone cancer	0.00647	0.00647	CcSEcCtD
Zanamivir—Neutropenia—Methotrexate—bone cancer	0.00646	0.00646	CcSEcCtD
Zanamivir—Dehydration—Doxorubicin—bone cancer	0.00644	0.00644	CcSEcCtD
Zanamivir—Dyspnoea—Cisplatin—bone cancer	0.00639	0.00639	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.00624	0.00624	CcSEcCtD
Zanamivir—Decreased appetite—Cisplatin—bone cancer	0.00623	0.00623	CcSEcCtD
Zanamivir—Bronchitis—Epirubicin—bone cancer	0.00622	0.00622	CcSEcCtD
Zanamivir—Pain—Cisplatin—bone cancer	0.00613	0.00613	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00611	0.00611	CcSEcCtD
Zanamivir—Neutropenia—Epirubicin—bone cancer	0.00605	0.00605	CcSEcCtD
Zanamivir—Influenza—Doxorubicin—bone cancer	0.00599	0.00599	CcSEcCtD
Zanamivir—Asthma—Doxorubicin—bone cancer	0.00599	0.00599	CcSEcCtD
Zanamivir—Feeling abnormal—Cisplatin—bone cancer	0.0059	0.0059	CcSEcCtD
Zanamivir—Bronchitis—Doxorubicin—bone cancer	0.00576	0.00576	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00572	0.00572	CcSEcCtD
Zanamivir—Body temperature increased—Cisplatin—bone cancer	0.00566	0.00566	CcSEcCtD
Zanamivir—Neutropenia—Doxorubicin—bone cancer	0.0056	0.0056	CcSEcCtD
Zanamivir—Haemoglobin—Methotrexate—bone cancer	0.00556	0.00556	CcSEcCtD
Zanamivir—Haemorrhage—Methotrexate—bone cancer	0.00553	0.00553	CcSEcCtD
Zanamivir—Sinusitis—Epirubicin—bone cancer	0.00541	0.00541	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00529	0.00529	CcSEcCtD
Zanamivir—Hypersensitivity—Cisplatin—bone cancer	0.00528	0.00528	CcSEcCtD
Zanamivir—Erythema multiforme—Methotrexate—bone cancer	0.00523	0.00523	CcSEcCtD
Zanamivir—Haemoglobin—Epirubicin—bone cancer	0.0052	0.0052	CcSEcCtD
Zanamivir—Haemorrhage—Epirubicin—bone cancer	0.00518	0.00518	CcSEcCtD
Zanamivir—Asthenia—Cisplatin—bone cancer	0.00514	0.00514	CcSEcCtD
Zanamivir—Sinusitis—Doxorubicin—bone cancer	0.00501	0.00501	CcSEcCtD
Zanamivir—Chills—Methotrexate—bone cancer	0.00496	0.00496	CcSEcCtD
Zanamivir—Diarrhoea—Cisplatin—bone cancer	0.0049	0.0049	CcSEcCtD
Zanamivir—Erythema multiforme—Epirubicin—bone cancer	0.0049	0.0049	CcSEcCtD
Zanamivir—Haemoglobin—Doxorubicin—bone cancer	0.00481	0.00481	CcSEcCtD
Zanamivir—Haemorrhage—Doxorubicin—bone cancer	0.00479	0.00479	CcSEcCtD
Zanamivir—Chills—Epirubicin—bone cancer	0.00465	0.00465	CcSEcCtD
Zanamivir—Arrhythmia—Epirubicin—bone cancer	0.00463	0.00463	CcSEcCtD
Zanamivir—Vomiting—Cisplatin—bone cancer	0.00455	0.00455	CcSEcCtD
Zanamivir—Erythema multiforme—Doxorubicin—bone cancer	0.00453	0.00453	CcSEcCtD
Zanamivir—Rash—Cisplatin—bone cancer	0.00452	0.00452	CcSEcCtD
Zanamivir—Dermatitis—Cisplatin—bone cancer	0.00451	0.00451	CcSEcCtD
Zanamivir—Ill-defined disorder—Methotrexate—bone cancer	0.00447	0.00447	CcSEcCtD
Zanamivir—Malaise—Methotrexate—bone cancer	0.00434	0.00434	CcSEcCtD
Zanamivir—Chills—Doxorubicin—bone cancer	0.0043	0.0043	CcSEcCtD
Zanamivir—Arrhythmia—Doxorubicin—bone cancer	0.00428	0.00428	CcSEcCtD
Zanamivir—Nausea—Cisplatin—bone cancer	0.00425	0.00425	CcSEcCtD
Zanamivir—Cough—Methotrexate—bone cancer	0.0042	0.0042	CcSEcCtD
Zanamivir—Ill-defined disorder—Epirubicin—bone cancer	0.00418	0.00418	CcSEcCtD
Zanamivir—Convulsion—Methotrexate—bone cancer	0.00417	0.00417	CcSEcCtD
Zanamivir—Agitation—Epirubicin—bone cancer	0.00414	0.00414	CcSEcCtD
Zanamivir—Arthralgia—Methotrexate—bone cancer	0.0041	0.0041	CcSEcCtD
Zanamivir—Myalgia—Methotrexate—bone cancer	0.0041	0.0041	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00407	0.00407	CcSEcCtD
Zanamivir—Malaise—Epirubicin—bone cancer	0.00406	0.00406	CcSEcCtD
Zanamivir—Discomfort—Methotrexate—bone cancer	0.00405	0.00405	CcSEcCtD
Zanamivir—Syncope—Epirubicin—bone cancer	0.00404	0.00404	CcSEcCtD
Zanamivir—Confusional state—Methotrexate—bone cancer	0.00396	0.00396	CcSEcCtD
Zanamivir—Loss of consciousness—Epirubicin—bone cancer	0.00396	0.00396	CcSEcCtD
Zanamivir—Cough—Epirubicin—bone cancer	0.00393	0.00393	CcSEcCtD
Zanamivir—Anaphylactic shock—Methotrexate—bone cancer	0.00393	0.00393	CcSEcCtD
Zanamivir—Convulsion—Epirubicin—bone cancer	0.00391	0.00391	CcSEcCtD
Zanamivir—Infection—Methotrexate—bone cancer	0.0039	0.0039	CcSEcCtD
Zanamivir—Ill-defined disorder—Doxorubicin—bone cancer	0.00387	0.00387	CcSEcCtD
Zanamivir—Arthralgia—Epirubicin—bone cancer	0.00384	0.00384	CcSEcCtD
Zanamivir—Myalgia—Epirubicin—bone cancer	0.00384	0.00384	CcSEcCtD
Zanamivir—Agitation—Doxorubicin—bone cancer	0.00383	0.00383	CcSEcCtD
Zanamivir—Anxiety—Epirubicin—bone cancer	0.00382	0.00382	CcSEcCtD
Zanamivir—Skin disorder—Methotrexate—bone cancer	0.00382	0.00382	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00381	0.00381	CcSEcCtD
Zanamivir—Discomfort—Epirubicin—bone cancer	0.00379	0.00379	CcSEcCtD
Zanamivir—Malaise—Doxorubicin—bone cancer	0.00376	0.00376	CcSEcCtD
Zanamivir—Anorexia—Methotrexate—bone cancer	0.00375	0.00375	CcSEcCtD
Zanamivir—Syncope—Doxorubicin—bone cancer	0.00374	0.00374	CcSEcCtD
Zanamivir—Confusional state—Epirubicin—bone cancer	0.00371	0.00371	CcSEcCtD
Zanamivir—Anaphylactic shock—Epirubicin—bone cancer	0.00368	0.00368	CcSEcCtD
Zanamivir—Loss of consciousness—Doxorubicin—bone cancer	0.00367	0.00367	CcSEcCtD
Zanamivir—Infection—Epirubicin—bone cancer	0.00365	0.00365	CcSEcCtD
Zanamivir—Cough—Doxorubicin—bone cancer	0.00364	0.00364	CcSEcCtD
Zanamivir—Shock—Epirubicin—bone cancer	0.00362	0.00362	CcSEcCtD
Zanamivir—Convulsion—Doxorubicin—bone cancer	0.00361	0.00361	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00358	0.00358	CcSEcCtD
Zanamivir—Skin disorder—Epirubicin—bone cancer	0.00357	0.00357	CcSEcCtD
Zanamivir—Arthralgia—Doxorubicin—bone cancer	0.00355	0.00355	CcSEcCtD
Zanamivir—Myalgia—Doxorubicin—bone cancer	0.00355	0.00355	CcSEcCtD
Zanamivir—Anxiety—Doxorubicin—bone cancer	0.00354	0.00354	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00353	0.00353	CcSEcCtD
Zanamivir—Discomfort—Doxorubicin—bone cancer	0.00351	0.00351	CcSEcCtD
Zanamivir—Anorexia—Epirubicin—bone cancer	0.00351	0.00351	CcSEcCtD
Zanamivir—Dyspnoea—Methotrexate—bone cancer	0.0035	0.0035	CcSEcCtD
Zanamivir—Confusional state—Doxorubicin—bone cancer	0.00343	0.00343	CcSEcCtD
Zanamivir—Decreased appetite—Methotrexate—bone cancer	0.00342	0.00342	CcSEcCtD
Zanamivir—Anaphylactic shock—Doxorubicin—bone cancer	0.0034	0.0034	CcSEcCtD
Zanamivir—Fatigue—Methotrexate—bone cancer	0.00339	0.00339	CcSEcCtD
Zanamivir—Infection—Doxorubicin—bone cancer	0.00338	0.00338	CcSEcCtD
Zanamivir—Pain—Methotrexate—bone cancer	0.00336	0.00336	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00335	0.00335	CcSEcCtD
Zanamivir—Shock—Doxorubicin—bone cancer	0.00335	0.00335	CcSEcCtD
Zanamivir—Skin disorder—Doxorubicin—bone cancer	0.00331	0.00331	CcSEcCtD
Zanamivir—Dyspnoea—Epirubicin—bone cancer	0.00328	0.00328	CcSEcCtD
Zanamivir—Anorexia—Doxorubicin—bone cancer	0.00324	0.00324	CcSEcCtD
Zanamivir—Feeling abnormal—Methotrexate—bone cancer	0.00324	0.00324	CcSEcCtD
Zanamivir—Gastrointestinal pain—Methotrexate—bone cancer	0.00321	0.00321	CcSEcCtD
Zanamivir—Decreased appetite—Epirubicin—bone cancer	0.0032	0.0032	CcSEcCtD
Zanamivir—Fatigue—Epirubicin—bone cancer	0.00317	0.00317	CcSEcCtD
Zanamivir—Pain—Epirubicin—bone cancer	0.00315	0.00315	CcSEcCtD
Zanamivir—Urticaria—Methotrexate—bone cancer	0.00312	0.00312	CcSEcCtD
Zanamivir—Body temperature increased—Methotrexate—bone cancer	0.00311	0.00311	CcSEcCtD
Zanamivir—Abdominal pain—Methotrexate—bone cancer	0.00311	0.00311	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.0031	0.0031	CcSEcCtD
Zanamivir—Dyspnoea—Doxorubicin—bone cancer	0.00303	0.00303	CcSEcCtD
Zanamivir—Feeling abnormal—Epirubicin—bone cancer	0.00303	0.00303	CcSEcCtD
Zanamivir—Gastrointestinal pain—Epirubicin—bone cancer	0.00301	0.00301	CcSEcCtD
Zanamivir—Decreased appetite—Doxorubicin—bone cancer	0.00296	0.00296	CcSEcCtD
Zanamivir—Fatigue—Doxorubicin—bone cancer	0.00293	0.00293	CcSEcCtD
Zanamivir—Urticaria—Epirubicin—bone cancer	0.00292	0.00292	CcSEcCtD
Zanamivir—Pain—Doxorubicin—bone cancer	0.00291	0.00291	CcSEcCtD
Zanamivir—Body temperature increased—Epirubicin—bone cancer	0.00291	0.00291	CcSEcCtD
Zanamivir—Abdominal pain—Epirubicin—bone cancer	0.00291	0.00291	CcSEcCtD
Zanamivir—Hypersensitivity—Methotrexate—bone cancer	0.0029	0.0029	CcSEcCtD
Zanamivir—Asthenia—Methotrexate—bone cancer	0.00282	0.00282	CcSEcCtD
Zanamivir—Feeling abnormal—Doxorubicin—bone cancer	0.0028	0.0028	CcSEcCtD
Zanamivir—Gastrointestinal pain—Doxorubicin—bone cancer	0.00278	0.00278	CcSEcCtD
Zanamivir—Hypersensitivity—Epirubicin—bone cancer	0.00271	0.00271	CcSEcCtD
Zanamivir—Urticaria—Doxorubicin—bone cancer	0.0027	0.0027	CcSEcCtD
Zanamivir—Body temperature increased—Doxorubicin—bone cancer	0.00269	0.00269	CcSEcCtD
Zanamivir—Abdominal pain—Doxorubicin—bone cancer	0.00269	0.00269	CcSEcCtD
Zanamivir—Diarrhoea—Methotrexate—bone cancer	0.00269	0.00269	CcSEcCtD
Zanamivir—Asthenia—Epirubicin—bone cancer	0.00264	0.00264	CcSEcCtD
Zanamivir—Dizziness—Methotrexate—bone cancer	0.0026	0.0026	CcSEcCtD
Zanamivir—Diarrhoea—Epirubicin—bone cancer	0.00252	0.00252	CcSEcCtD
Zanamivir—Hypersensitivity—Doxorubicin—bone cancer	0.00251	0.00251	CcSEcCtD
Zanamivir—Vomiting—Methotrexate—bone cancer	0.0025	0.0025	CcSEcCtD
Zanamivir—Rash—Methotrexate—bone cancer	0.00248	0.00248	CcSEcCtD
Zanamivir—Dermatitis—Methotrexate—bone cancer	0.00248	0.00248	CcSEcCtD
Zanamivir—Headache—Methotrexate—bone cancer	0.00246	0.00246	CcSEcCtD
Zanamivir—Asthenia—Doxorubicin—bone cancer	0.00244	0.00244	CcSEcCtD
Zanamivir—Dizziness—Epirubicin—bone cancer	0.00243	0.00243	CcSEcCtD
Zanamivir—Vomiting—Epirubicin—bone cancer	0.00234	0.00234	CcSEcCtD
Zanamivir—Nausea—Methotrexate—bone cancer	0.00233	0.00233	CcSEcCtD
Zanamivir—Diarrhoea—Doxorubicin—bone cancer	0.00233	0.00233	CcSEcCtD
Zanamivir—Rash—Epirubicin—bone cancer	0.00232	0.00232	CcSEcCtD
Zanamivir—Dermatitis—Epirubicin—bone cancer	0.00232	0.00232	CcSEcCtD
Zanamivir—Headache—Epirubicin—bone cancer	0.0023	0.0023	CcSEcCtD
Zanamivir—Dizziness—Doxorubicin—bone cancer	0.00225	0.00225	CcSEcCtD
Zanamivir—Nausea—Epirubicin—bone cancer	0.00218	0.00218	CcSEcCtD
Zanamivir—Vomiting—Doxorubicin—bone cancer	0.00216	0.00216	CcSEcCtD
Zanamivir—Rash—Doxorubicin—bone cancer	0.00215	0.00215	CcSEcCtD
Zanamivir—Dermatitis—Doxorubicin—bone cancer	0.00214	0.00214	CcSEcCtD
Zanamivir—Headache—Doxorubicin—bone cancer	0.00213	0.00213	CcSEcCtD
Zanamivir—Nausea—Doxorubicin—bone cancer	0.00202	0.00202	CcSEcCtD
